Wildcard: The Next Nano-X, But With Less Risk
Industry Focus - Een podcast door The Motley Fool
Categorieën:
HyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC. Stocks: HealthCor Catalio Acquisition Corp (HCAQ) Check out more of our content here: Podcasts Youtube Twitter Reach us by Email @ [email protected]
